These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17986803)

  • 1. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
    Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
    Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
    Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
    Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
    Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
    Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic vessel density as prognostic factor in breast carcinoma: relation to clinicopathologic parameters.
    El-Gendi S; Abdel-Hadi M
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):139-49. PubMed ID: 21057565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
    Marinho VF; Metze K; Sanches FS; Rocha GF; Gobbi H
    BMC Cancer; 2008 Feb; 8():64. PubMed ID: 18307818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
    Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
    Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers.
    He KW; Sun JJ; Liu ZB; Zhuo PY; Ma QH; Liu ZY; Yu ZY
    Medicine (Baltimore); 2017 Nov; 96(44):e8490. PubMed ID: 29095309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer.
    Kozłowski M; Naumnik W; Nikliński J; Milewski R; Lapuć G; Laudański J
    Folia Histochem Cytobiol; 2011; 49(1):90-7. PubMed ID: 21526494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
    Wahal SP; Goel MM; Mehrotra R
    J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.
    Debald M; Pölcher M; Flucke U; Walgenbach-Brünagel G; Walgenbach KJ; Höller T; Wolfgarten M; Rudlowski C; Büttner R; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1128-33. PubMed ID: 20133078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
    Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
    Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between D2-40-labeled lymphatic vessel invasion and lymph node metastasis of breast cancer].
    Ding GP; Ye CS; Liu MF; Zhen LF; Liao JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2301-3. PubMed ID: 20965831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.
    Perry C; Soomro I; Kaye P; Hardy E; Parsons SL; Ragunath K; Lobo DN; Martin SG; Madhusudan S
    Dis Esophagus; 2015 Apr; 28(3):262-8. PubMed ID: 24612464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].
    Martini T; Ströbel P; Steidler A; Petrakopoulou N; Erben P; Bolenz C
    Urologe A; 2015 Jan; 54(1):70-5. PubMed ID: 25391439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.